期刊
CRITICAL REVIEWS IN FOOD SCIENCE AND NUTRITION
卷 62, 期 19, 页码 5307-5321出版社
TAYLOR & FRANCIS INC
DOI: 10.1080/10408398.2021.1884532
关键词
Tea ingredients; polyphenol derivatives; nutritional therapy; inflammatory bowel disease
资金
- National Nature Science Foundation of China [31570075, 31800037, 31770133]
- Jiangxi Province Science Foundation for Youths [20171BAB214001]
Inflammatory bowel disease (IBD) is a chronic gastrointestinal disorder with unknown causes. Tea, with its active ingredients like tea polyphenols, has shown potential benefits for preventing and treating IBD due to its anti-inflammatory and antioxidant properties, opening up possibilities for further research on tea derivatives as novel therapeutic agents for IBD.
Inflammatory bowel disease (IBD) is a chronic gastro-intestinal disorders of unknown etiology. There are several drugs approved for treating IBD patients with active disease, including first-line use of aminosalicylates, and secondary choices of immunomodulators and other therapies. These medications might manage disease symptoms, but have also shown significant side-effects in IBD patients. Tea is the second largest beverage in the world and its main active ingredients including tea polyphenols, polysaccharides and tea pigments have been shown promising anti-inflammatory and antioxidant properties. In this review, we summarize the influence of different tea varieties including green tea, black tea and dark tea as potential nutritional therapy for preventing and treating IBD, and discuss the mechanisms of tea ingredients involved in the regulation of oxidative stress, inflammation, signaling pathways, and gut microbiota that could benefit for IBD disease management. Our observation directs further basic and clinical investigations on tea polyphenols and their derivatives as novel IBD therapeutic agents.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据